ConMed Reports 2Q16 Orthopaedic Revenue
ConMed posted 2Q16 arthroscopy/soft tissue revenue of US $92.7MM, -4.2% vs. 2Q15. (U.S. -5.1%, ex-U.S. -3.6%) All growth is as-reported.
U.S. and ex-U.S. growth was affected by a decline in capital sales, which leadership attributed to challenges in execution, competitive sales and deal-closings that were pushed to 3Q.
In an update to products mentioned in the 1Q16 call, leadership noted that:
- The TenoLoc Dual Expanding Tenodesis anchor is now in full U.S. launch
- The AssistArm limb positioner is launched U.S. and ex-U.S.
- The Edge Bi-Polar Arthroscopic RF System has been implemented at multiple sites in Canada, Spain and the U.S.
Sources: ConMed Corporation, ORTHOWORLD Inc.